mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.51 |
0.09 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.09 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |